Daniel Lang Athenex, Inc. (ATNX) insider trading activity
Daniel Lang is Pres Cell Therapy, VP Corp Dev of Athenex, Inc.. Currently has a direct ownership of 81,590 shares of ATNX, which is worth approximately $815. The most recent transaction as insider was on Sep 16, 2022, when has been sold 4,323 shares (Common Stock) at a price of $0.41 per share, resulting in proceeds of $1,772. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
81.6K
0%
3M change
0%
12M change
Total Value Held
$815
Daniel Lang Transaction History
DL
Daniel Lang
Pres Cell Therapy, VP Corp Dev
Buffalo, NY